Cargando…

Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocytopathy

BACKGROUND: Ofatumumab, a fully humanized anti-CD20 monoclonal antibody, has shown promising efficacy in limited cases of neuromyelitis optica spectrum disorder, but there is a lack of studies on its use in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy. We present a case of refrac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Shugang, Du, Jing, Pan, Sidi, Zhang, Juanjuan, Xu, Si, Wei, Ling, Tian, Yanghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200986/ https://www.ncbi.nlm.nih.gov/pubmed/37223100 http://dx.doi.org/10.3389/fimmu.2023.1164181

Ejemplares similares

Plasma exchange for two patients with autoimmune GFAP astrocytopathy with rapid progression to respiratory failure: a case report
por: Du, Jing, et al.
Publicado: (2023)

Serological biomarkers in autoimmune GFAP astrocytopathy
por: Fu, Cong-Cong, et al.
Publicado: (2022)

Autoimmune GFAP astrocytopathy after viral encephalitis: a case report of bimodal overlapping encephalitis
por: Cheng, Ping, et al.
Publicado: (2023)

Characteristics of Movement Disorders in Patients with Autoimmune GFAP Astrocytopathy
por: Kimura, Akio, et al.
Publicado: (2022)

Case report: Revealing a special and rare autoimmune GFAP astrocytopathy in the spinal cord succeeding Neurobrucellosis infection
por: He, Qiang, et al.
Publicado: (2022)

Elevated Levels of NLRP3 in Cerebrospinal Fluid of Patients With Autoimmune GFAP Astrocytopathy
por: Luo, Ying, et al.
Publicado: (2019)

Uncommon manifestations of a rare disease: a case of autoimmune GFAP astrocytopathy
por: Di, Hong, et al.
Publicado: (2021)

Case Report: Need for Caution in the Diagnosis of GFAP Astrocytopathy—A Case of GFAP Astrocytopathy Coexistent With Primary Central Nervous System Lymphoma
por: Fang, Jia, et al.
Publicado: (2022)

Rapidly progressive dementia: Extending the spectrum of GFAP‐astrocytopathies?
por: Friedrich, Maximilian, et al.
Publicado: (2022)

Area postrema syndrome with linear enhancement along the surface of the brainstem and fourth ventricle in autoimmune GFAP astrocytopathy
por: Liang, Xinming, et al.
Publicado: (2023)

A meaningful exploration of ofatumumab in refractory NMOSD: a case report
por: Zhan, Yibo, et al.
Publicado: (2023)

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature
por: Shan, Fulan, et al.
Publicado: (2018)

A case report of autoimmune GFAP astrocytopathy presenting with abnormal heart rate variability and blood pressure variability
por: Wen, Pu-yuan, et al.
Publicado: (2023)

Autoimmune-mediated astrocytopathy
por: Kinoshita, Makoto, et al.
Publicado: (2023)

Magnetic Resonance Imaging Characteristics of Autoimmune Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy: A Pediatric Series in Southwest China
por: Cheng, Weiqin, et al.
Publicado: (2023)

Radiographic evolution of myelitis in a case of glial fibrillary acidic protein (GFAP) astrocytopathy
por: Goyne, Christopher E, et al.
Publicado: (2023)

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases
por: Fang, Hongjun, et al.
Publicado: (2021)

Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
por: Héraud, Charlotte, et al.
Publicado: (2021)

Autoimmune glial fibrillary acidic protein astrocytopathy
por: Kunchok, Amy, et al.
Publicado: (2019)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: To Identify Its Diagnosis, Management and Prognosis (GFAP-AID) Registry: Study Protocol for an Ambispective, Multicenter Registry in China
por: Yang, Jie, et al.
Publicado: (2022)

Refractory pemphigus vulgaris successfully treated with ofatumumab
por: Klufas, Daniel M., et al.
Publicado: (2020)

Clinical characteristics and prognostic factors for short-term outcomes of autoimmune glial fibrillary acidic protein astrocytopathy: a retrospective analysis of 33 patients
por: Zhang, Wanwan, et al.
Publicado: (2023)

Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins
por: Dwojak, M, et al.
Publicado: (2015)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia
por: Tuscano, Joseph, et al.
Publicado: (2020)

Abnormal evoked potentials in autoimmune glial fibrillary acidic protein astrocytopathy
por: Tokimura, Ryo, et al.
Publicado: (2020)

Subacute Blindness Revealing an Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
por: Mabrouki, Fatima Zahra, et al.
Publicado: (2021)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis
por: Lundberg, Sigrid, et al.
Publicado: (2017)

Treatment of Refractory Pediatric Autoimmune Hepatitis With Rituximab
por: Saul, Samantha A., et al.
Publicado: (2021)

Ofatumumab Desensitization Protocol: A Case of Refractory Immune Thrombocytopenic Purpura
por: Cochran, Audra L, et al.
Publicado: (2023)

Autoimmune glial fibrillary acidic protein astrocytopathy in children: a retrospective study
por: Zhuang, Xiamei, et al.
Publicado: (2022)

Successful treatment of rituximab-unresponsive elderly-onset neuromyelitis optica spectrum disorder and hypogammaglobulinemia with ofatumumab plus intravenous immunoglobulin therapy in a patient with mutant FCGR3A genotype: A case report
por: Zhang, Weihe, et al.
Publicado: (2022)

Autoimmune glial fibrillary acidic protein astrocytopathy with lesions distributed predominantly in the entire spinal cord
por: Li, Xue-Lin, et al.
Publicado: (2020)

Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration
por: Torres, Julia Baguña, et al.
Publicado: (2022)

The case report of MOG and NMDAR IgG double positive encephalitis treated with subcutaneous ofatumumab
por: Zhang, Rui, et al.
Publicado: (2023)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

Immunotherapy for Refractory Autoimmune Encephalitis
por: Yang, Jiawei, et al.
Publicado: (2021)

Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination
por: Faissner, Simon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d4diomi8ogclg4l3o83nl4c5kp